Clorox (CLX) Receivables (2009 - 2026)

Clorox's Receivables history runs 18 years deep, the most recent figure standing at $671.0 million for Q1 2026.

• In Q1 2026, Receivables rose 12.4% year-over-year to $671.0 million; the TTM figure through Mar 2026 stood at $671.0 million (up 12.4% YoY), while the FY2025 annual figure was $837.0 million, up 14.03% from the prior year.
• Receivables was $671.0 million for Q1 2026 at Clorox, roughly flat from $671.0 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $837.0 million in Q2 2025 to a low of $581.0 million in Q3 2023.
• Historically, Receivables has averaged $664.6 million across 5 years, with a median of $671.0 million in 2025.
• Biggest YoY gain for Receivables was 18.15% in 2025; the steepest drop was 11.29% in 2025.
• A 5-year view of Receivables shows it stood at $600.0 million in 2022, then climbed by 13.17% to $679.0 million in 2023, then declined by 11.19% to $603.0 million in 2024, then advanced by 11.28% to $671.0 million in 2025, then changed by 0.0% to $671.0 million in 2026.
• The last three Receivables figures came in at $671.0 million (Q1 2026), $671.0 million (Q4 2025), and $703.0 million (Q3 2025), per Business Quant data.